Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2021.784044
Abstract: Cardiovascular diseases (CVDs) are still the main cause of morbidity and mortality worldwide and include a group of disorders varying from vasculature, myocardium, arrhythmias and cardiac development. MicroRNAs (miRs) are endogenous non-coding RNAs with 18–23… read more here.
Keywords: 34a cardiovascular; microrna 34a; cardiovascular diseases; 34a novel ... See more keywords
MicroRNA-34a: A Novel Therapeutic Target in Fibrosis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Physiology"
DOI: 10.3389/fphys.2022.895242
Abstract: Fibrosis can occur in many organs, and severe cases leading to organ failure and death. No specific treatment for fibrosis so far. In recent years, microRNA-34a (miR-34a) has been found to play a role in… read more here.
Keywords: target; novel therapeutic; 34a novel; mir 34a ... See more keywords